Glycemic Outcomes Of Dapagliflozin, Glimepiride, And Sitagliptin As Add-On Therapy To Metformin In Patients With Type 2 Diabetes Mellitus: A Prospective Observational Study. The Review of Diabetic Studies , [S. l.], p. 693–700, 2025. DOI: 10.70082/qs5vrk14. Disponível em: https://diabeticstudies.org/index.php/RDS/article/view/628. Acesso em: 7 oct. 2025.